ECONOMIC IMPACT OF TREATING SEVERE HEMOPHILIA A PATIENTS WITH PLASMA-DERIVED FACTOR-VIII/VWF VERSUS RECOMBINANT FACTOR-VIII IN THE UNITED STATES

被引：0

作者：

O'Day, K. ^{[1
]}

Runken, M. C. ^{[2
]}

Meyer, K. L. ^{[1
]}

Spears, J. B. ^{[2
]}

机构：

[1] Xcenda LLC, Palm Harbor, FL USA

[2] Grifols Inc, Res Triangle Pk, NC USA

来源：

VALUE IN HEALTH | 2017年 / 20卷 / 05期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSY46

引用

页码：A216 / A217

页数：2

共 50 条

[1] INHIBITOR QUESTIONS - PLASMA-DERIVED FACTOR-VIII AND RECOMBINANT FACTOR-VIII
BRAY, G
ANNALS OF HEMATOLOGY, 1994, 68 : S29 - S34
[2] RELATION OF ACTIVATED FACTOR-VIII TO THE POTENCY IN FACTOR-VIII CONCENTRATES, COMPARISON OF PLASMA-DERIVED AN RECOMBINANT FACTOR-VIII
MINAMIYAMA, T
ITO, Y
OGURI, S
KOBAYASHI, K
TAKEDA, M
THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 942 - 942
[3] RECOMBINANT FACTOR-VIII IN HEMOPHILIA
COHEN, A
BUTLER, R
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21): : 1515 - 1516
[4] IMPACT OF RECOMBINANT FACTOR-VIII ON HEMOPHILIA CARE
MANNUCCI, PM
VOX SANGUINIS, 1994, 67 : 49 - 52
[5] RECOMBINANT FACTOR-VIII IN HEMOPHILIA - REPLY
SCHWARTZ, R
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21): : 1516 - 1516
[6] Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States
Neufeld, Ellis J.
Sidonio, Robert F., Jr.
O'Day, Ken
Runken, M. Chris
Meyer, Kellie
Spears, Jeffrey
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) : 762 - 769
[7] RECENT ADVANCES IN THE PREPARATION OF PLASMA-DERIVED AND RECOMBINANT COAGULATION FACTOR-VIII
BRAY, GL
JOURNAL OF PEDIATRICS, 1990, 117 (03): : 503 - 507
[8] Plasma-derived versus recombinant factor VIII for the treatment of hemophilia A
Kasper, CK
VOX SANGUINIS, 1996, 70 : 17 - 20
[9] A CASE OF FACTOR-VIII AG-POSITIVE SEVERE HEMOPHILIA A WITH FACTOR-VIII INHIBITOR
SHIMA, M
IMAI, S
TSUBURA, Y
YOSHIOKA, A
FUJIMURA, Y
SUGIMOTO, M
FUKUI, H
THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 78 - 78
[10] VIRAL SAFETY ISSUES - PLASMA-DERIVED FACTOR-VIII
BERNTORP, E
ANNALS OF HEMATOLOGY, 1994, 68 : S35 - S36

← 1 2 3 4 5 →